³Ô¹ÏÍøÕ¾

Latest

Latest AusBiotech News

  • Latest AusBiotech news stories and updates. What is happening today? All recent AusBiotech news and developments. Live coverage and timeline of AusBiotech. All you need to know about AusBiotech.
Amplia enters into preclinical collaboration with Korean drug screening company
AusBiotech Announces Inaugural Depaz Oration
AusBiotech And MTPConnect Launch Joint Discussion Paper On Critical Life Science Growth Issues Ahead Of ³Ô¹ÏÍøÕ¾ Summit
Recce says patient dosing in Phase 2 clinical trial advances to final stages
Optiscan signs agreement with Monash to progress GI Scope
Imugene says bile tract cancer patient maintains complete response in MAST study
Helping hand for WA’s health and medical life sciences sector
Chimeric secures commitments for placement to progress development of CHM CDH17
Minister for Economic Growth and Minister for Jobs and Industry to both speak during Australia’s biggest week in biotech
Respiri announces it has secured a major strategic investment
Immuron Reports Continued Sales Growth For Travelan
AusBiotech Board of Directors Election Notification 2024
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
Federal Minister for Health and Aged Care to speak at Australia’s biggest week in biotech
Mesoblast option to issue up to US$50 million convertible notes for product launch
Percheron Therapeutics updates on Avicursen primate toxicology study
PolyNovo announces the retirement of long-term non-executive director
AusBiotech welcomes more new mmembers from across Australia’s life sciences ecosystem
Argenica reports positive results in IND-enabling trials
Chimeric announces new collaboration with Achieve Clinics
Insights To Innovation: Bridging Funding Gap
Notification Of AGM 2024
Immutep receives $3.6 million R&D tax incentive from French Government
Telix to acquire North American manufacturing and distribution platform
Landmark MoU to boost WA’s biomedical innovation opportunities
AusBiotech and MTPConnect partner to deliver Australian first ³Ô¹ÏÍøÕ¾ Summit
Cochlear Announces Chief Financial Officer Appointment
Invion updates on Phase 2 prostate cancer trial of INV043
Immune cell could become ‘off-the-shelf’ rapid tissue, muscle and bone healing therapy
PharmAust says EMA pre-submission meeting paves the way for orphan designation request
Remembering Biotech Trailblazer Leon Serry AM
New Centre To Be Key In Global AI Medical Research
Telix’s Phase 3 ZIRCON trial for kidney cancer imaging published in The Lancet Oncology
Victorians gain access to precision cancer therapies following landmark donation
AusBiotech welcomes release of HTA Review’s final report
Vaxxas initiates Phase 1 clinical trial of pre-pandemic Avian Influenza A Virus vaccine
Biotron updates on BIT225-012 Phase 2 COVID-19 clinical trial
Nyrada provides update on its brain injury program GLP studies
AusBiotech Appoints Industry Growth Program Manager
CSL announces sale of Wuhan plasma collection and fractionation operations
Opthea announces executive leadership changes and senior appointments
Noxopharm reports results from Chroma platform drug development program
Lumos Diagnostics announces equity raise and welcomes major new shareholder
Strengthening Australia-Hong Kong health and investment ties
Race Oncology announces the detail of first phase of board renewal
Percheron Therapeutics announces positive preclinical data for avicursen
Telix submits NDA for TLX101-CDx brain cancer imaging agent
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy

© 2024 - ³Ô¹ÏÍøÕ¾